Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Author(s) -
Chenguang Shen,
Zhaoqin Wang,
Fang Zhao,
Yang Yang,
Jinxiu Li,
Jing Yuan,
Fuxiang Wang,
Delin Li,
Minghui Yang,
Li Xing,
Jinli Wei,
Haixia Xiao,
Yan Yang,
Jiuxin Qu,
Ling Qing,
Li Chen,
ZhiXiang Xu,
Ling Peng,
Yanjie Li,
Haixia Zheng,
Feng Chen,
Kun Huang,
Yujing Jiang,
Dongjing Liu,
Zheng Zhang,
Yingxia Liu,
Lei Liu
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2020.4783
Subject(s) - medicine , ards , convalescent plasma , convalescence , titer , pneumonia , mechanical ventilation , covid-19 , intensive care medicine , immunology , emergency medicine , disease , antibody , infectious disease (medical specialty) , lung
Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality. It is critical to find new treatments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom